about
Sulfonylurea receptor 1 in central nervous system injury: a focused reviewP-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociceptionIn normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain.The embryonic blood-cerebrospinal fluid barrier function before the formation of the fetal choroid plexus: role in cerebrospinal fluid formation and homeostasisGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierNanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelMR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused UltrasoundGalanin-induced decreases in nucleus accumbens/striatum excitatory postsynaptic potentials and morphine conditioned place preference require both galanin receptor 1 and galanin receptor 2.Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.Manganese toxicity upon overexposure.Quantitation of microvascular plasma perfusion and neuronal microtubule-associated protein in ischemic mouse brain by laser-scanning confocal microscopy.Barrier mechanisms in the brain, I. Adult brain.Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular spaceImage-guided convection-enhanced delivery of muscimol to the primate brainExpression and function of multidrug resistance transporters at the blood-brain barriers.Blood-brain barrier preservation in the in vitro isolated guinea pig brain preparation.Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain.A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.Antisense therapy in neurologyNeuroprotection with noninvasive neurotrophin delivery to the brain.Noninvasive gene targeting to the brainIntracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.Antisense imaging of gene expression in the brain in vivoCan formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.Convection-enhanced delivery for the treatment of pediatric neurologic disorders.Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.Nanotechnology for delivery of drugs to the brain for epilepsy.IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditionsBiphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory painAldosterone induces rapid sodium intake by a nongenomic mechanism in the nucleus tractus solitariusC-type natriuretic peptide modulates permeability of the blood-brain barrierInsulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.Functions of mature mammalian astrocytes: a current view.Functions of astrocytes and their potential as therapeutic targets.Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.On the possible use of exogenous histones in cell technology.Current options for drug delivery to the spinal cord.
P2860
Q24606564-0109C7F0-6DBA-488A-91B5-BC8055E22095Q24631289-5747EB4F-6F95-4B6F-8964-D4C9F6572ECCQ24815635-C17EB0F6-A839-4238-A6E8-57DD0ED4EE93Q26860525-B00E79CB-A314-4354-8A2C-C6D3323FACDDQ28071873-8F180AFE-A813-4F86-A5EB-FCAFAD9BB0A6Q28075999-429B7EB7-B934-4E5F-80C1-357A164E4B09Q28481345-FDF5B0D7-B161-4CD0-B824-36440516B09AQ28817563-8087C644-8057-4454-8D1E-B669C51D6563Q30539653-AB7C8221-9E8E-4F99-8B08-5A4E2230CBFAQ30672749-DD463E3A-8DE7-4B2E-83A0-520D67E4BCE6Q30979177-0C567CBA-E56D-4447-B94A-541CAFD64BB6Q31935306-44A6C3EB-9706-4B16-AC3C-5D847837176AQ33535015-29C31F7D-6571-497F-80F2-36AF5BF7A655Q33657728-5773C602-AC4F-4D84-A5DF-B5F855605094Q33699338-CB199412-CA97-45AD-B090-DEB8F6014A47Q33785767-B026FE04-E84A-453E-A54E-BB40C47C86FBQ33998841-6A134A37-D85D-4BC1-BFEC-492E4292E782Q34094253-8E0C38F1-5D1C-4C56-BF74-C31815B4F5F6Q34389429-751A6A51-6167-4400-8F19-3E8D3A97CB29Q34550143-2ACD9E60-6847-4A01-9FA6-A4E206C6ECECQ34608717-300CA5F3-2EB5-4264-9F49-06FF23DBF5C7Q34802946-F73D3FB3-E3AF-449A-97F1-08029E637E64Q35163431-D05F49F1-D715-40E6-8886-6BA59DADEF1CQ35504426-3D14720A-EACE-4E88-942F-1FD51A3DE879Q35853732-A9D742AC-8AA0-4E76-8920-B9E8A2A0B12BQ36111924-FFC70262-FCE7-4C91-8413-ECE74B1F2EB9Q36684355-C2C688F7-6BBA-4C8C-947F-8334C1EC6426Q36907531-242C1CAE-9B15-4224-911E-6364CCD80343Q37250532-DD9E3C32-B567-4F9B-8D5F-54B793B15BBFQ37426991-19F93035-408A-4BEF-9899-EA997CF04D8AQ37479916-CB119464-32BD-4EC1-B665-4BCA3A4FAC54Q37483383-D40FEFA2-CA2F-42E6-A8C4-F366FF9F4BB8Q37487356-122BD0FE-0996-4520-9D02-A90D3D2A4527Q37695310-715442F2-F353-4B15-BB93-E4A82447CECAQ37710673-EBB8F044-3B24-43BA-9406-22DB98EE9D0CQ37710857-46729AA4-373D-4A24-A7F8-E5DBB6E7DF81Q37794378-E16AD023-B46B-4FF4-873A-E21289A23E1DQ37946305-F6D1359E-8A48-4275-B3EB-0EACEA8DA53CQ37954394-7A2E9720-0655-4B56-90C8-C6D3F80F373AQ38071680-388631FF-B1DE-43BF-AE1F-95D94830460D
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Drug delivery to the brain.
@en
type
label
Drug delivery to the brain.
@en
prefLabel
Drug delivery to the brain.
@en
P2860
P1476
Drug delivery to the brain.
@en
P2860
P304
P356
10.1097/00004647-199707000-00001
P577
1997-07-01T00:00:00Z
P5875
P6179
1010101701